Chia Tai Enterprises International Limited (3839.HK)
- Previous Close
0.670 - Open
0.680 - Bid 0.640 x --
- Ask 0.660 x --
- Day's Range
0.650 - 0.680 - 52 Week Range
0.650 - 2.300 - Volume
47,000 - Avg. Volume
51,244 - Market Cap (intraday)
158.874M - Beta (5Y Monthly) 3.30
- PE Ratio (TTM)
8.25 - EPS (TTM)
0.080 - Earnings Date May 10, 2024 - May 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment products portfolio consists of CTC premix and CTC hydrochloride, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.
www.ctei.com.hk1,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 3839.HK
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3839.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3839.HK
Valuation Measures
Market Cap
161.28M
Enterprise Value
478.97M
Trailing P/E
8.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.12
Price/Book (mrq)
0.09
Enterprise Value/Revenue
2.75
Enterprise Value/EBITDA
97.81
Financial Highlights
Profitability and Income Statement
Profit Margin
1.47%
Return on Assets (ttm)
-0.78%
Return on Equity (ttm)
0.74%
Revenue (ttm)
173.98M
Net Income Avi to Common (ttm)
2.55M
Diluted EPS (ttm)
0.080
Balance Sheet and Cash Flow
Total Cash (mrq)
37.61M
Total Debt/Equity (mrq)
31.02%
Levered Free Cash Flow (ttm)
--